Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In receptor-deficient systems, the peptide does not produce measurable changes in lipolytic signaling, supporting the conclusion that its effects are mediated through adrenergic pathway engagement rather than direct hormone receptor activation
L-tyrosine, citicoline, alpha-GPC, and the racetams have thinner support, though not none
However, this is a top-line result announced by the company, and as of July 2026, it remains an unapproved investigational drug
6:859-869 [PubMed: 30292589] 321
So naturally, the next question is: Is there actual evidence for this in human cells
This is where GLP-1 medications can be particularly valuable tools
US$ 22.09
US$ 25.34
US$ 29.75
US$ 22.84
US$ 21.96
US$ 24.66
US$ 23.31
